HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Chiasson, J.-L. Articles by Rabasa-Lhoret, R. Search for Related Content PubMed PubMed Citation Articles by Chiasson, J.-L. Articles by Rabasa-Lhoret, R. Social Bookmarking                What's this?

Prevention of Type 2 Diabetes

Insulin Resistance and Beta-Cell Function

From the Research Centre, Centre Hospitalier de l’Université de Montréal–Hôtel-Dieu, and the Department of Medicine and Nutrition, University of Montreal, Montreal, Quebec, Canada

Type 2 diabetes is increasing worldwide in epidemic proportions. Its associated morbidity and mortality is imposing a major burden on the health care system. Based on a better understanding of the pathophysiology of glucose intolerance, clinical trials on the prevention of diabetes have been performed. It has now been demonstrated that diet and exercise, metformin, acarbose, and troglitazone can prevent or at least delay the development of diabetes in subjects with impaired glucose tolerance (IGT). It is now generally accepted that insulin resistance and ß-cell dysfunction are major factors involved in the development of diabetes. The relative contribution of insulin resistance versus ß-cell dysfunction on the pathogenesis of diabetes has aroused much debate. These two processes should be studied in relation to one another: their relationship is best described as hyperbolic in nature. When this relationship is taken into consideration, it becomes evident that subjects at risk of developing type 2 diabetes have ß-cell dysfunction before they develop glucose intolerance. Insulin resistance may be mostly explained by the presence of obesity and accelerate the progression to diabetes in subjects with the propensity to ß-cell failure. By the time hyperglycemia occurs, impairment in both insulin sensitivity and insulin secretion are present. There are still few data on insulin sensitivity and insulin secretion from the trials on the prevention of diabetes. The few data that we do have suggest that most interventions mostly have an effect on insulin resistance. By reducing insulin resistance, they protect and preserve the ß-cell function. No intervention has yet shown any direct effect on ß-cell function.

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				T. O. Kilpelainen, T. A. Lakka, D. E. Laaksonen, O. Laukkanen, J. Lindstrom, J. G. Eriksson, T. T. Valle, H. Hamalainen, S. Aunola, P. Ilanne-Parikka, et al. Physical activity modifies the effect of SNPs in the SLC2A2 (GLUT2) and ABCC8 (SUR1) genes on the risk of developing type 2 diabetes Physiol Genomics, October 19, 2007; 31(2): 264 - 272. [Abstract] [Full Text] [PDF]

				D. Pomplun, A. Voigt, T. J. Schulz, R. Thierbach, A. F. Pfeiffer, and M. Ristow Reduced expression of mitochondrial frataxin in mice exacerbates diet-induced obesity PNAS, April 10, 2007; 104(15): 6377 - 6381. [Abstract] [Full Text] [PDF]

				D. E Laaksonen, L. K Toppinen, K. S Juntunen, K. Autio, K.-H. Liukkonen, K. S Poutanen, L. Niskanen, and H. M Mykkanen Dietary carbohydrate modification enhances insulin secretion in persons with the metabolic syndrome Am. J. Clinical Nutrition, December 1, 2005; 82(6): 1218 - 1227. [Abstract] [Full Text] [PDF]